Latest Breaking News On - Rushmie nofsinger - Page 1 : comparemela.com

Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting

CAMBRIDGE, Mass. (BUSINESS WIRE) Jun 3, 2024

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani

CAMBRIDGE, Mass. (BUSINESS WIRE) Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced the appointm.

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass. (BUSINESS WIRE) Nov 17, 2023

Scholar Rock Holding Corporation (NASDAQ:SRRK) Q3 2023 Earnings Call Transcript

Rushmie Nofsinger: Good morning. I m Rushmie Nofsinger, Vice President of Corporate Affairs and Investor Relations at Scholar Rock.